Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
James W. Welsh, John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman, Vivek Verma, Kenneth R. Hess, Girish S. Shroff, Chad Tang, Ferdinandos Skoulidis, Melenda Jeter, Nathan Comeaux, Roshal R. Patel, Dawei Chen, Tugce Ozgen, Quynh-Nhu Nguyen, Joe Y. Chang, Mehmet Altan, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, George R. Simon, Lauren A. Byers, Bonnie S. Glisson
Topics & Concepts
MedicinePembrolizumabCommon Terminology Criteria for Adverse EventsInternal medicineNeutropeniaOncologyPneumonitisChemoradiotherapyRadiation therapyProgression-free survivalSurgeryChemotherapyCancerImmunotherapyLungLung Cancer Research StudiesNanoplatforms for cancer theranosticsIntraperitoneal and Appendiceal Malignancies